Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies
Science · 17.03.2023 · 379 (6637) · 1140-1149
DOI: 10.1126/science.abq5622 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 17.03.2023. Verfasst von Michael W Baughn und 23 weiteren Autor:innen. Beteiligte Einrichtung: Ludwig Institute for Cancer Research, University of California at San Diego, La Jolla, CA 92093, USA. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Polyadenylation, Stathmin, TDP-43 Proteinopathies. Die Arbeit wurde bisher 249-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIA NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Loss of nuclear TDP-43 is a hallmark of neurodegeneration in TDP-43 proteinopathies, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). TDP-43 mislocalization results in cryptic splicing and polyadenylation of pre–messenger RNAs (pre-mRNAs) encoding stathmin-2 (also known as SCG10), a protein that is required for axonal regeneration. We found that TDP-43 binding to a GU-rich region sterically blocked recognition of the cryptic 3′ splice site in STMN2 pre-mRNA. Targeting dCasRx or antisense oligonucleotides (ASOs) suppressed cryptic splicing, which restored axonal regeneration and stathmin-2–dependent lysosome trafficking in TDP-43–deficient human motor neurons. In mice that were gene-edited to contain human STMN2 cryptic splice-polyadenylation sequences, ASO injection into cerebral spinal fluid successfully corrected Stmn2 pre-mRNA misprocessing and restored stathmin-2 expression levels independently of TDP-43 binding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ludwig Institute for Cancer Research, University of California at San Diego, La Jolla, CA 92093, USA.
- Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA 92093, USA.
- Department of Medical Neurobiology, Faculty of Medicine, The Hebrew University of Jerusalem, Israel.
- Ionis Pharmaceuticals, Carlsbad, CA 92010, USA.
- Rare Disease Translational Center, The Jackson Laboratory, Bar Harbor, ME 04609, USA.
- Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
ORCID-Profile: Michael W Baughn, Ze'ev Melamed, Melinda S Beccari, Karen Ling, Aamir Zuberi, Maximilliano Presa, Sonia Vazquez-Sanchez, Mariana Bravo-Hernández, I Sandra Ndayambaje, Ana R Agra de Almeida Quadros, Paayman Jafar-Nejad, C Frank Bennett, Clotilde Lagier-Tourenne, Don W Cleveland
Förderung
- NINDS NIH HHS
- NIA NIH HHS
- NCI NIH HHS
- NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Baughn, M. W., Melamed, Z., López-Erauskin, J., Beccari, M. S., Ling, K., Zuberi, A., Presa, M., Gonzalo-Gil, E., Maimon, R., Vazquez-Sanchez, S., Chaturvedi, S., Bravo-Hernández, M., Taupin, V., Moore, S., Artates, J. W., Acks, E., Ndayambaje, I. S., Agra de Almeida Quadros, A. R., Jafar-Nejad, P., …, & Cleveland, D. W. (2023). Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies. Science, 379(6637), 1140-1149. https://doi.org/10.1126/science.abq5622
Vancouver
Baughn MW, Melamed Z, López-Erauskin J, Beccari MS, Ling K, Zuberi A, et al. Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies. Science. 2023;379(6637):1140-1149. doi:10.1126/science.abq5622
BibTeX
@article{Baughn2023,
author = {Baughn, Michael W and Melamed, Ze'ev and López-Erauskin, Jone and Beccari, Melinda S and Ling, Karen and Zuberi, Aamir and Presa, Maximilliano and Gonzalo-Gil, Elena and Maimon, Roy and Vazquez-Sanchez, Sonia and Chaturvedi, Som and Bravo-Hernández, Mariana and Taupin, Vanessa and Moore, Stephen and Artates, Jonathan W and Acks, Eitan and Ndayambaje, I Sandra and Agra de Almeida Quadros, Ana R and Jafar-Nejad, Paayman and Rigo, Frank and Bennett, C Frank and Lutz, Cathleen and Lagier-Tourenne, Clotilde and Cleveland, Don W},
title = {Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies},
journal = {Science},
year = {2023},
volume = {379},
number = {6637},
pages = {1140--1149},
doi = {10.1126/science.abq5622}
}
EUVIMED